New Study: Cannabidiol Protects Brain and Spine in MS Patients
Multiple Sclerosis is a debilitating disease that often strikes in the prime of life. In its inexorable progress it strips away the myeline sheath in the white matter of the brain and spinal cord. This results in a progressive cascade of symptoms including bladder problems, difficulty walking, dizziness, fatigue, muscle spasms, sexual disfunction and abnormal sensations.
For years, MS patients have claimed that smoking cannabis provides symptomatic relief, and reduces suffering. Research published in the forthcoming November 2013 online issue of Neurobiology shows why that may be so. As the title of the study states: Cannabidial provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis.
Cannabidiol (CBD), a non-psychotropic cannabinoid found in cannabis is a immune regulator, which has potent anti-inflammatory and immunosuppressive properties. Researchers at Cajal Institute in Spain, found that treatment with CBD has long-term positive effects, and improves motor deficits associated with the disease. It limits the harmful effects of a runaway inflammatory response found in MS, and can prevent the development of secondary and irreversible damage.
Treating MS early is one of the ways to slow progression of the disease. Since CBD is non-psychotropic in effect, and since the beginning of MS are often masked, with symptoms showing up after the disease has already progressed and damaged nerves, it makes sense to view CBD in terms of prevention. Keeping MS at bay, particularly in those who are predisposed to the disease may be as simple as taking CBD as a supplement, much in the way vitamin c prevents scurvy.